iA Global Asset Management Inc. Acquires 347 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

iA Global Asset Management Inc. grew its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 40.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,199 shares of the medical instruments supplier’s stock after buying an additional 347 shares during the period. iA Global Asset Management Inc.’s holdings in Mettler-Toledo International were worth $1,467,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. boosted its holdings in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after buying an additional 28,478 shares in the last quarter. M&T Bank Corp boosted its holdings in shares of Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after buying an additional 615 shares in the last quarter. Allworth Financial LP boosted its holdings in shares of Mettler-Toledo International by 367.4% during the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock worth $285,000 after buying an additional 169 shares in the last quarter. Nordea Investment Management AB boosted its holdings in shares of Mettler-Toledo International by 29.8% during the 4th quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock worth $129,919,000 after buying an additional 24,285 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its holdings in shares of Mettler-Toledo International by 18.0% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock worth $42,058,000 after purchasing an additional 5,234 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company’s stock, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, February 10th. Wolfe Research assumed coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. Robert W. Baird increased their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Evercore ISI increased their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Finally, Citigroup cut their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $1,380.50.

Mettler-Toledo International Trading Down 0.2 %

Shares of NYSE:MTD opened at $1,198.09 on Friday. The stock’s fifty day simple moving average is $1,292.72 and its two-hundred day simple moving average is $1,310.84. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93. The stock has a market cap of $24.97 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, sell-side analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.